» Articles » PMID: 15564463

Coordination of Transcription Factor Phosphorylation and Histone Methylation by the P-TEFb Kinase During Human Immunodeficiency Virus Type 1 Transcription

Overview
Journal J Virol
Date 2004 Nov 27
PMID 15564463
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

The human immunodeficiency virus type 1 (HIV-1) Tat protein recruits positive transcription elongation factor b (P-TEFb) to the transactivation response (TAR) RNA structure to facilitate formation of processive transcription elongation complexes (TECs). Here we examine the role of the Tat/TAR-specified cyclin-dependent kinase 9 (CDK9) kinase activity in regulation of HIV-1 transcription elongation and histone methylation. In HIV-1 TECs, P-TEFb phosphorylates the RNA polymerase II (RNAP II) carboxyl-terminal domain (CTD) and the transcription elongation factors SPT5 and Tat-SF1 in a Tat/TAR-dependent manner. Using in vivo chromatin immunoprecipitation analysis, we demonstrate the following distinct properties of the HIV-1 transcription complexes. First, the RNAP II CTD is phosphorylated at Ser 2 and Ser 5 near the promoter and at downstream coding regions. Second, the stable association of SPT5 with the TECs is dependent upon P-TEFb kinase activity. Third, P-TEFb kinase activity is critical for the induction of methylation of histone H3 at lysine 4 and lysine 36 on HIV-1 genes. Flavopiridol, a potent P-TEFb kinase inhibitor, inhibits CTD phosphorylation, stable SPT5 binding, and histone methylation, suggesting that its potent antiviral activity is due to its ability to inhibit several critical and unique steps in HIV-1 transcription elongation.

Citing Articles

NVP-2, in combination with Orlistat, represents a promising therapeutic strategy for acute myeloid leukemia.

Zhu Q, Cheng J, Gao Y, Zhang Z, Pan J, Su X Cancer Biol Ther. 2025; 26(1):2450859.

PMID: 39800696 PMC: 11730633. DOI: 10.1080/15384047.2025.2450859.


HIV-1 Gag co-localizes with euchromatin histone marks at the nuclear periphery.

Chang J, Parent L J Virol. 2023; 97(12):e0117923.

PMID: 37991367 PMC: 10734548. DOI: 10.1128/jvi.01179-23.


Transcriptional Stochasticity as a Key Aspect of HIV-1 Latency.

Damour A, Slaninova V, Radulescu O, Bertrand E, Basyuk E Viruses. 2023; 15(9).

PMID: 37766375 PMC: 10535884. DOI: 10.3390/v15091969.


In search of therapeutic candidates for HIV/AIDS: rational approaches, design strategies, structure-activity relationship and mechanistic insights.

Kumar D, Sharma P, Shabu , Kaur R, Lobe M, Gupta G RSC Adv. 2022; 11(29):17936-17964.

PMID: 35480193 PMC: 9033207. DOI: 10.1039/d0ra10655k.


Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription.

DeMarino C, Cowen M, Khatkar P, Cotto B, Branscome H, Kim Y Cells. 2022; 11(4).

PMID: 35203372 PMC: 8869966. DOI: 10.3390/cells11040723.


References
1.
Sadaie M, Hager G . Induction of developmentally programmed cell death and activation of HIV by sodium butyrate. Virology. 1994; 202(1):513-8. DOI: 10.1006/viro.1994.1372. View

2.
Taube R, Fujinaga K, Wimmer J, Barboric M, Peterlin B . Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation. Virology. 1999; 264(2):245-53. DOI: 10.1006/viro.1999.9944. View

3.
Rodriguez C, Cho E, Keogh M, Moore C, Greenleaf A, Buratowski S . Kin28, the TFIIH-associated carboxy-terminal domain kinase, facilitates the recruitment of mRNA processing machinery to RNA polymerase II. Mol Cell Biol. 1999; 20(1):104-12. PMC: 85066. DOI: 10.1128/MCB.20.1.104-112.2000. View

4.
Schang L, Rosenberg A, Schaffer P . Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins. J Virol. 2000; 74(5):2107-20. PMC: 111691. DOI: 10.1128/jvi.74.5.2107-2120.2000. View

5.
Wada T, Takagi T, Yamaguchi Y, Ferdous A, Imai T, Hirose S . DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev. 1998; 12(3):343-56. PMC: 316480. DOI: 10.1101/gad.12.3.343. View